Lillestol Research

< Return to trials

Obesity

Overview

Lillestol Research has proven to be a tremendous asset to a sponsor with our trial experience in the obesity indication/diagnosis, and we are anxiously awaiting our next trial opportunity in this area. The community response to our first trial in this indication was overwhelmingly positive. Our research patient database holds nearly 2,500 individuals with an obesity diagnosis that would be interested in clinical trial participation.

Spotlight Trial(s)

This was an after-market trial evaluating a weight loss medication’s affect on the risk of developing cardiovascular disease in individuals who are overweight or obese, and who have cardiovascular disease or risk factors. Lillestol Research was able to successfully meet and far exceed the sponsor’s enrollment expectation randomizing 86 patients in a 12-month enrollment period.